In a ROC analysis involving 90 patients, exosomal miR-1290 demonstrated superior diagnostic efficiency compared to CEA, CYFRA21–1, and NSE in discriminating between NSCLC patients and healthy controls (150). This evidence concerns the gene ENO2 and non-small cell lung carcinoma.